Neisseria meningitidis with decreased susceptibility to penicillin in Istanbul, Turkey

Metin Punar1, Haluk Eraksoy, A Atahan Cagatay

  • 1Department of Clinical Bacteriology and Infectious Diseases, Istanbul Faculty of Medicine, Istanbul University, Capa, Turkey.

Insights

This study found high penicillin resistance in Neisseria meningitidis isolates in Istanbul, Turkey. Surveillance is crucial to monitor antimicrobial susceptibility trends and prevent therapeutic challenges from resistant meningococcal strains.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Neisseria meningitidis is a significant cause of bacterial meningitis.
  • Decreased susceptibility to penicillin in N. meningitidis can complicate treatment.
  • Monitoring antimicrobial resistance patterns is essential for public health.

Purpose of the Study:

  • To estimate the prevalence of decreased penicillin susceptibility in N. meningitidis isolates from Istanbul, Turkey.
  • To assess resistance to cefotaxime in conjunction with penicillin.
  • To highlight the importance of ongoing antimicrobial susceptibility surveillance.

Main Methods:

  • Collected 30 N. meningitidis isolates from clinical cases and nasopharyngeal carriers over one year.
  • Utilized the E-test method to determine Minimum Inhibitory Concentrations (MICs) for penicillin and cefotaxime.
  • Categorized isolates based on established susceptibility breakpoints for penicillin.

Main Results:

  • An overall decreased susceptibility to penicillin was observed in 43% (13/30) of isolates.
  • Higher rates of decreased susceptibility were found in nasopharyngeal isolates (61%) compared to clinical isolates (17%).
  • MIC values for resistant isolates ranged from 0.094 to 1.0 microg/ml.

Conclusions:

  • A significant proportion of N. meningitidis isolates in Istanbul exhibit decreased susceptibility to penicillin.
  • Nasopharyngeal carriage may harbor a higher prevalence of penicillin-reduced susceptibility.
  • Continuous monitoring of N. meningitidis antimicrobial susceptibility is vital to anticipate and manage potential therapeutic failures.

Related Concept Videos

Bacterial Meningitis01:24

Bacterial Meningitis

Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Production of Antibiotics01:27

Production of Antibiotics

Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...